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The ubiquitous octamer-binding protein 
Oct-1 contains a POU domain with a 
homeo box subdomain 
Richard A. Sturm, Gokul Das, and Winship Herr 
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 USA 
The octamer motif ATGCAAAT is recognized indistinguishably by two mammalian transcription factors: one 
that is expressed ubiquitously and referred to here as Oct-l, and another, Oct-2, that is expressed in lymphoid 
cells. We report the cDNA cloning of the human oct-1 gene, which encodes Oct-l, by screening kgtl 1 
recombinant phage in situ for octamer motif-specific DNA binding. One ~gtl 1 recombinant expressed a ~- 
galactosidase-octamer-binding fusion pr tein with a DNA-binding specificity indistinguishable from human 
HeLa cell Oct-1 protein. As expected for a ubiquitously expressed protein, Oct-1 mRNA is expressed in all five 
human and two mouse cell lines tested. Polyclonal rabbit antiserum raised against the B-galactosidase fusion 
protein shows that the DNA-binding domains of Oct-1 and Oct-2 proteins are related antigenically. Deletion 
analysis of the 743-amino-acid-long oct-1 open reading frame shows that the DNA-binding activity lies within 
a central highly charged domain of 160 amino acids. Comparison of the Oct-1 and Oct-2 sequences reveals that 
this domain is nearly identical between the two proteins. Highly similar domains are also present in the 
pituitary-specific transcription factor Pit-1 and the Caenorhabditis elegans unc-86 cell lineage gene product (see 
Herr et al. 1988). Within this shared POU (_Pit-l, Oct-1 and Oct-2, tmc-86) domain (pronounced 'pow') lie two 
subdomains: a POU-related homeo box and a POU-specific box. The Oct-1 protein is unique among the POU- 
related proteins and other homeo box proteins because it is expressed ubiquitously. 
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Transcriptional regulation depends largely on the se- 
quence-specific nteraction of trans-activator proteins 
with cis-acting promoter elements. Sequence-specific 
trans-activators contain two essential domains for func- 
tion: a DNA-binding domain and a trans-activation do- 
main. As first shown by fusion of the bacterial exA 
DNA-binding domain to the yeast GAL4 trans-activa- 
tion domain (Brent and Ptashne 1985), these domains 
can be interchanged. The specificity of transcriptional 
activation is conferred by the DNA-binding domain, 
which targets the trans-activator to the promoter car- 
rying a corresponding DNA-binding site(s) (for review, see 
Ptashne 1988). To date, trans-activation domains have 
displayed little promoter specificity. For example, the 
yeast GAL4 trans-activator can stimulate a variety of 
promoters in mammalian cells provided that GAL4 
DNA-binding sites are located in the vicinity of the pro- 
moter {Kakidani and Ptashne 1988; Ptashne 1988; Web- 
ster et al. 1988). Nevertheless, more than one class of 
trans-activation domain may exist because GAL4 fails 
to activate a U2 small nuclear RNA (snRNA) promoter 
containing GAL4 DNA-binding sites in mammalian 
cells (Tanaka et al. 1988). 
The lymphoid-specific and ubiquitous octamer/de- 
camer (ATGCAAATNA)-motif-binding proteins provide 
a model system to study conservation of DNA-binding 
specificity, as well as to elucidate trans-activation speci- 
ficity. The octamer motif {Falkner and Zachau 1984; 
Parslow et al. 1984), or closely related sequences, is a 
functional element in the promoters of the ubiquitously 
expressed snRNA (Ares et al. 1985; Mattaj et al. 1985; 
Mangin et al. 1986; Carbon et al. 1987) and histone H2B 
genes {LaBella et al. 1988; Sturm et al. 1988), a lym- 
phoid-specific element in immunoglobulin upstream 
and enhancer regions (Falkner and Zachau 1984; Mason 
et al. 1985; Gerster et al. 1987; Lenardo et al. 1987; 
Wirth et al. 1987), and a DNA replication element in the 
adenovirus origin of replication (Pruijn et al. 1986; Ro- 
senfeld et al. 1987). Two factors that bind indistinguish- 
ably to the octamer motif have been purified. One, first 
referred to as NF-A1 (Staudt et al. 1986), is ubiquitously 
expressed, and the other, first called NF-A2 (Staudt et al. 
1986), is restricted to lymphoid cells (Landolfi et al. 
1986; Singh et al. 1986; Staudt et al. 1986; Rosales et al. 
1987; Scheidereit et al. 1987). A 90- to 100-kD protein 
responsible for the ubiquitous octamer-binding activity 
has been purified from HeLa cells in several laboratories 
and variously referred to as OTF-1 (Fletcher et al. 1987), 
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OBP100 (Sturm et al. 1987), or NFIII (O'Neill and Kelly 
1988). OTF-1 and NFIII, which were initially shown to 
stimulate histone H2B transcription and adenovirus rep- 
lication, respectively, are identical proteins (O'Neill et 
al. 1988); OBP100 is probably also identical to OTF-1/ 
NFIII. The lymphoid-specific octamer-binding protein 
OTF-2 has also been purified (Scheidereit et al. 1987; 
Hanke et al. 1988) and stimulates transcription of an im- 
munoglobulin light-chain K promoter in vitro (Schei- 
dereit et al. 1987). 
The different expression patterns of the ubiquitous oc- 
tamer-binding protein, which we refer to here as Oct-l, 
and the lymphoid-specific octamer-binding protein, 
Oct-2 (Cleft et al. 1988, this issue), parallel the activity 
of the octamer motif in different contexts. In the context 
of a variety of RNA polymerase II promoters that direct 
expression of polyadenylated mRNAs (e.g., immuno- 
globulin, B-globin, SV40 early), the octamer motif dis- 
plays B-cell-specific enhancer function (Davidson et al. 
1986; Gerster et al. 1987; Wirth et al. 1987; Tanaka et al. 
1988). But in the context of the U2 snRNA promoter, 
which is also transcribed by RNA polymerase II (Freder- 
iksen et al. 1978; Gram Jensen et al. 1979), the octamer 
motif itself displays enhancer function in non-B cells 
(Mattaj et al. 1985; Ares et al. 1987; Tanaka et al. 1988). 
The different patterns of octamer motif function in a 
snRNA promoter, compared with the [~-globin promoter, 
suggest hat the ubiquitous octamer-binding protein be- 
longs to a different class of trans-activators. Thus, the 
ubiquitous Oct-1 and lymphoid-specific Oct-2 proteins 
are an excellent pair of trans-activators with which to 
study both conservation of DNA sequence recognition 
and divergence of trans-activation function. 
We report here the isolation of human eDNA clones 
encoding ubiquitously expressed octamer-binding pro- 
tein, referred to here as the oct-1 gene. First isolated as a 
kgtl 1 B-galactosidase fusion protein by the in situ DNA 
filter detection method (Singh et al. 1988; Staudt et al. 
1988; Vinson et al. 1988), this protein meets several cri- 
teria (i.e., DNA-binding specificity, ubiquitous expres- 
sion, antigenic relationship, and size) that indicate it is 
the ubiquitously expressed octamer-binding protein var- 
iously called OTF-1, NFIII, and OBP100. Comparison of 
the Oct-1 and lymphoid Oct-2 (Clerc et al. 1988) amino 
acid sequences reveals a highly conserved region, 160 
amino acids long, that contains the DNA-binding do- 
main and is also present in the pituitary transcription 
factor Pit-1 (Ingraham et al. 1988) and the Caenorhab- 
ditis elegans homeotic unc-86 gene product (Finney et 
al. 1988; see Herr et al. 1988, this issue). 
Results 
Isolation of ~C5: a ~gtII human eDNA recombinant 
encoding a f$-galactosidase,-octamer-binding fusion 
protein 
To isolate a eDNA clone of the ubiquitously expressed 
octamer-binding protein, we probed a human ~.gtll 
eDNA expression library for octamer-specific DNA- 
Molecular cloning of oct-1 
binding proteins by the in situ filter detection method 
(Singh et al. 1988; Staudt et al. 1988) using denaturation 
of filter-bound proteins to enhance the signal (Vinson et 
al. 1988). Because of the widespread expression pattern 
of the ubiquitous octamer-binding protein, we chose to 
screen a readily available ~,gtl 1 eDNA library derived 
from the human teratocarcinoma cell line NTera-2D1 
(constructed by J. Skowronski; SenGupta et al. 1986). 
This cell line displays elevated levels of ubiquitous oc- 
tamer-binding activity (data not shown) and mRNA ex- 
pression (see below). We screened 4 x l0 s plaques with 
a radiolabeled multimerized SV40 octamer motif and 
identified one plaque (termed kCS) that bound the probe 
effectively. Figure 1A shows that this binding is specific. 
Replica filter lifts from plates containing either partially 
purified ~,C5 phage or L20 phage, which express a ~-ga- 
lactosidase-C/EBP fusion protein that binds specifically 
to C/EBP-binding sites (Landschulz et al. 1988b; Vinson 
et al. 1988), were probed with either the octamer motif 
or C/EBP-binding sites. Each recombinant fusion protein 
bound only to its corresponding probe (Fig. 1A). 
To examine the B-galactosidase-octamer-binding fu- 
sion protein expressed by KC5, bacterial extracts were 
prepared from ~C5-, Kgtll-, and L20-infected cells and 
fractionated on a polyacrylamide g l (Fig. 1B). Compared 
with the uninfected cell extract (lane 5), the ~CS-in- 
fected cell extract contains a 190- to 200-kD protein and 
a series of smaller proteins of -150-190 kD. The ~C5-, 
~,gtll-, and L20-encoded proteins were also tested for 
binding to the octamer motif after transfer to a filter. 
The larger of the KC5-specific proteins bound to the oc- 
tamer motif probe (Fig. 1C, lane 2), but f~-galactosidase 
(~,gtl 1) and the C/EBP fusion protein (L20) did not bind 
to the probe. The low level of binding by the major 150- 
to 190-kD products present in Figure 1B suggests that 
many of these smaller KC5 proteins are missing the oc- 
tamer motif DNA-binding domain. Some of the smaller 
proteins do, however, bind the octamer motif (Fig. 1C, 
lane 2), which may explain the heterogeneous pattern of 
complex formation observed in the gel retardation 
assays described below. 
DNA binding specificity of the ~C5 fusion protein 
To establish the authenticity of the octamer-specific 
DNA-binding activity of the kC5 fusion protein, we 
tested its affinity for a number of known binding and 
nonbinding sites for the HeLa cell octamer-binding pro- 
tein OBP100 in a gel retardation assay. OBP100 displays 
remarkably flexible DNA-binding specificity (Sturm et
al. 1987; Baumruker et al. 1988); in addition to binding 
to perfect octamer motifs [e.g., the immunoglobulin 
heavy-chain (IgH) enhancer octamer motif, ATG- 
CAAAT], OBP100 binds to two degenerate SV40 oc- 
tamer motifs and to the herpes simplex virus (HSV) 
TAATGARAT consensus equence, which represents a 
very degenerate octamer motif (Baumruker et al. 1988). 
Figure 2 shows a comparison of the binding activities of 
Escherichia coli-derived ~,C5 fusion protein and the par- 
tially purified OBP100 protein from HeLa cells. These 
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Figure 1. Octamer motif binding of the kC5 fPgalactosi- 
dase fusion protein. (A) Two replica filter lifts from plates 
containing partially purified kC5 or the C/EBP-binding 
bacteriophage L20 were each screened reciprocally with 
a2p-labeled 14xB17 restriction fragment (OBP probe) or a 
ligated oligomer containing a C/EBP-binding site (C/EBP 
probe; Vinson et al. 1988). Each probe was radiolabeled by 
nick-translation and added to the respective filters at 
1 x l0 s cpm/ml after processing the filters by the guani- 
dine hydrochloride denaturation/renaturation procedure 
(Vinson et al. 1988). (B) One milliliter of log-phase E. coli 
strain Y1089 uninfected or infected with kC5, Xgtll, or 
L20 at 5 pfu/cell was heat-shocked and subsequently 
treated with 10 m~ IPTG for 1 hr. The cells were collected 
by centrifugation, and 20% of the total cell protein was 
fractionated on an 8% polyacrylamide-SDS gel after 
boiling in SDS-loading buffer. The fractionated proteins 
were visualized by Coomassie blue staining. {Lane 1) Bio- 
Rad high-molecular-weight markers; (lane 2) hC5-infected 
cells; (lane 3) hgtl 1-infected cells; (lane 4) L20-infected ex- 
tracts; (lane 5) uninfected cell extract. (C) Southwestern 
blot analysis was performed on four tracks equivalent to 
lanes I--4 in B. Following electrotransfer to nitrocellulose, 
the filter was probed with nick-translated 14xB17 restric- 
tion fragment, as in A, without denaturation/renaturation 
treatment. 
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two proteins display the same relative affinity for each 
of these sites. The best binding site is the wild-type IgH 
enhancer octamer motif [lanes 1 and 2). The kC5-in- 
fected cell extract forms a major complex with a reduced 
mobility, compared with the bona fide OBP100 complex. 
This is consistent with the binding of the larger 190- to 
200-kD hC5 fusion protein. The more rapidly migrating 
complexes with the E. coli extract may reflect interac- 
tions with smaller OBP fusion peptides present in the 
infected cell extract (see Fig. 1C). Whatever the case, all 
of the hC5-specific complexes are also octamer specific 
because two point mutations within the nearly perfect 
SV40 Octal octamer motif [AaGgAAAG; dpm8), which 
abolish OBP100 binding (Sturm et al. 1987; cf. lanes 3 
and 4, Fig. 2}, also prevent binding of all the kC5 fusion 
proteins {cf. lanes 5 and 61. 
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Figure 2. The hC5 p-galactosidase fusion protein dis- 
plays the same relative affinity for multiple octamer 
protein-binding sites as HeLa-cell-derived OBP100. An 
E. cod extract was prepared from XC5-infected cells (see 
Materials and methods) and DNA-binding activity as- 
sayed and compared to a partially purified OBP100 
fraction from HeLa cells [Sturm et al. 1987) on three 
well-characterized OBPl00-binding sitesand two non- 
functional binding sites. Longer exposures of autoradio- 
grams of the gel retardations produced by the bacterial 
extract are shown to compensate for the lower binding 
activity of the hC5-infected E. coli extract. The major 
octamer-specific complexes are indicated by the 
bracket and labeled CI. Restriction fragment probes end 
labeled with 32p were assayed with either the HeLa or 
E. coli extracts, as described n Materials and methods, 
and indicated here. {Lanes 1, 2) A PstI-HindlII fragment 
containing 226 bp of the murine IgH heavy-chain en- 
hancer with a perfect consensus octamer motif ATG- 
CAAAT [described in Sturm et al. 1987) and EcoRI- 
PstI restriction fragments from pUCll9 containing 
binding sites cloned into the SmaI site; [lanes 3/7 and 
5/10) SV40 Octal-binding site; (lanes 4, 6) SV40 Octal 
with dpm8 mutations; [lanes 8, 11) the unrelated SV40 
enhancer sequence core A; {lanes 9, 12) the HSV 
TAATGARAT sequence found to bind OBP100 
(Baumruker et al. 1988). 
The most stringent est of KC5 fusion protein-binding 
specificity is the assay of TAATGARAT motif binding 
shown in lanes 7-12 of Figure 2. The SV40 Octal site 
(lanes 7 and 10) and TAATGARAT motif used here 
(lanes 9 and 12) are matched at only 4 out of 14 positions 
within the OBP100-binding site (Baumruker et al. 1988). 
OBP100 and the KC5 fusion protein display the same rel- 
ative affinity for these two binding sites (cf. lanes 7 and 
9, and 10 and 12) but do not bind to an unrelated frag- 
ment (coreA, lanes 8 and 11). The relative affinity of hC5 
fusion protein for a series of mutant and wild-type SV40 
OBP100 site II sequences (Baumruker et al. 1988) was 
also similar to OBP100 (data not shown). Thus, the hCS- 
expressed protein displays the same binding specificity 
as authentic ubiquitous HeLa cell octamer-binding pro- 
tein. In accordance with the nomenclature of Staudt et 
al. (1988) and Clerc et al. (1988), we refer to the gene 
encoding this octamer-binding protein as oct-1 and to 
the protein as Oct-1. 
The oct-/gene is expressed in all human and mouse 
cell lines tested 
We expect the gene encoding the ubiquitous octamer- 
binding protein to be expressed ubiquitously. To detect 
expression, we performed an RNase protection assay, 
probing cytoplasmic RNAs from five human and two 
mouse cell lines with an antisense oct-1 RNA probe. 
This assay is very sensitive and stringent, because mis- 
matches within an RNA-RNA duplex are targets for 
cleavage by RNase (Winter et al. 1985). Thus, it is a 
gene-specific expression assay. Figure 3 shows the result 
of probing cytoplasmic RNA from the human cell lines 
NTera-2D1, from which the cDNA library was derived; 
HeLa, either grown in spinner culture or on plates; 293, 
an adenovirus early-region-transformed mbryonic 
kidney cell line; WI-38, a nontransformed lung fibroblast 
cell strain; and BJAB, a B-cell line containing ahigh con- 
centration of the lymphoid-specific o t-2 mRNA (Staudt 
et al. 1988). The two mouse cell lines tested were 
NIH-3T3, and NS-1, a B-cell line. The human cell line 
RNAs all protect he complete oct-1 complementary se- 
quences (468 nucleotides; see the asterisk in Fig. 3) 
within the probe (Fig. 3, lanes 2, 4, 6, 8, 9, and 10). Alkali 
treatment of the human RNA samples (lanes 3, 5, 7, and 
11) prior to hybridization abolishes the signal, showing 
that the probe is being protected by RNA and not con- 
taminating chromosomal DNA. The levels of oct-1 RNA 
are similar in each cell line except that the NTera-2D1 
cell line has elevated oct-1 RNA levels (about three- to 
fivefold) and the WI-38 cell strain expresses less oct-1 
RNA. These differences may reflect the relative growth 
rates of these cells because the NTera-2D1 cells grow 
rapidly, whereas the nontransformed WI-38 cells prolif- 
erate less rapidly. 
Assay of the two mouse cell lines confirms that the 
protection assay is gene specific because the probe is no 
longer fully protected (Fig. 3, lanes 12 and 13). Instead, 
four shorter fragments (identified by the black dots) ap- 
pear. These fragments probably represent RNase 
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Figure 3. oct-1 mRNA expression in human and mouse cell lines. An 
RNase protection assay was performed using an internally labeled oct-1 
antisense-RNA probe generated by T3 RNA polymerase from a tem- 
plate prepared by HaeIII digestion of pBSXC51.1 +, which contains the 5' 
1.1-kb oct-1 EcoRI fragment from XC5 cloned into pBSM13 +. Except for 
the NIH-3T3 sample, which contained 10 ~g of RNA, 20 ~g of total 
cytoplasmic RNAs were hybridized, treated with RNase A and T1, and 
fractionated on a 6% denaturing polyacrylamide g l as described (Zinn 
et al. 1983). (Lane 1) Undigested probe alone; (lane 14) mock protection 
assay done in the absence of complementary RNA. Human cell line 
RNAs: {lanes 2,3) NTera-2D1; [lanes 4, 5)HeLa cells from spinner cul- 
ture; (lanes 6, 7) HeLa cells grown o  plates; (lane 8) 293; {lane 9) WI-38; 
{lanes 10, 11) BJAB. Lanes labeled OH- (3, 5, 7, 11) contained RNA 
samples that had been hydrolyzed by pretreatment with 0.6 Ivi sodium 
hydroxide for 5-10 min at ambient emperature, followed by neutral- 
ization with acetic acid and ethanol precipitation. The 468-nucleotide- 
long fragment (nucleotides 642-1109 in Fig. 5A) protected in all of the 
human RNA samples is marked by an asterisk (*), and the appearance of 
a B-cell-specific band i  the BJAB sample is indicated by an arrowhead. 
The mouse cell lines were NS-1 (lane 12) and NIH-3T3 (lane 13); the 
positions of four major protected fragments i  these samples are indi- 
cated by black dots. 
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cleavage at mismatches between the human antisense 
probe and mouse oct-1 transcripts. The antisense oct-1 
probe appears to cross-hybridize to oct-2 mRNA because 
an additional -100-nucleotide-long oct-1 probe frag- 
ment is protected in the BJAB-derived RNA (Fig. 3, lane 
10, see arrowhead). This protected fragment is consis- 
tent with the very high degree of homology between the 
oct-1 and oct-2 genes within a portion of the region 
spanned by this probe (see below). 
Ubiquitous and lymphoid.specific octamer-binding 
proteins are related antigenically 
The experiments described above show that the protein 
encoded by the kC5 eDNA clone has the same DNA- 
binding specificity as HeLa cell octamer-binding protein 
and that the gene is expressed ubiquitously. To verify 
further the relationship between ubiquitous octamer- 
binding protein and the kC5 fusion protein, we prepared 
a rabbit antiserum directed against he f~-galactosidase- 
octamer-binding fusion protein (see Materials and 
methods). To test the effects of this antiserum on Oct-1 
DNA binding, different dilutions of the antiserum (into 
preimmune serum) were added to binding reactions with 
partially purified OBP100, and the effects on complex 
formation in a gel retardation assay are shown in Figure 
4A. In these experiments, we observe a general and re- 
producible nhancement of complex formation by addi- 
tion of preimmune rabbit serum, which is even more 
marked in the assays hown in Figure 4, B and C. Never- 
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Figure 4. Rabbit anti-Oct-1 antiserum inhibits ubiquitous and lymphoid-specific octamer-binding activities. (A) A standard gel retar- 
dation assay (see Materials and methods) was performed using the wild-type SV40 site I probe in a 10-~1 binding mix containing a
partially purified HeLa cell fraction enriched for OBP100. The effect of adding to the prebinding mix, either no rabbit antiserum (lane 
1); 1 ~1 preimmune antiserum (lane 2); 1 ~1 immune serum (lane 3); 1 ~1 1 : 10 dilution immune serum (lane 4); 1 ~1 of 1:100 dilution 
immune serum (lane 5). All immune serum dilutions were done with preimmune antiserum. Note the appearance of a second retarda- 
tion complex (C*) upon dilution of the immune serum. (B) An XhoI end-filled fragment containing the SV40 Octal site was incubated 
with a total nuclear extract (Dignam et al. 1983) prepared from BJAB cells. The ubiquitous and B-cell-specific omplexes NF-A1 and 
NF-A2 (Staudt et al. 1986) are indicated. Antisera were added to the binding mixes for lanes 1-5, as in A. (C) An end-labeled EcoRI- 
HindIII fragment containing the c-los SRE (Gilman 1988) was used in a binding mix with a heparin-agarose fractionated nuclear 
extract from H9 cells enriched for SRF (a gift from W. Ryan). The antisera dded to the samples in lanes 1-5 were as described in A. 
The strong enhancement of sequence-specific complex formation in B and C is a nonspecific effect of the added sera. The exact 
explanation for this effect is not known but may reflect a general enhancing effect of the added protein from the serum. 
theless, addition of the XC5 immune antiserum to the 
partially purified HeLa nuclear extract abolishes oc- 
tamer-specific omplex formation (Fig. 4A, lane 3) but 
not formation of complexes between the unrelated 
serum response factor (SRF) and the c-fos serum re- 
sponse element (SRE) (Fig. 4C, lanes 2-5). Tenfold dilu- 
tion of the immune serum with the preimmune serum 
restored much of the octamer-specific complex but also 
generated a new complex with reduced mobility, labeled 
C* (lane 4). Further 10-fold dilution of the antiserum 
eliminated the C* complex and restored complex forma- 
tion to the same level as with the preimmune serum. 
We interpret these effects on octamer motif/Oct-1 
complex formation as follows. At high concentrations, 
antibodies in the immune antiserum that are directed 
against the Oct-1 DNA-binding domain prevent com- 
plex formation. Upon dilution of the immune anti- 
serum, the concentration of DNA-binding domain-spe- 
cific antibodies is insufficient o inhibit all complex for- 
mation. At this concentration, antibodies directed 
against epitopes of the Oct-1 protein that are not in- 
volved in DNA binding can piggyback onto the Oct-1 
protein/DNA complexes and create the C" complex. 
These results show that the kG5 fusion protein is re- 
lated antigenically to the ubiquitous octamer-binding 
protein. Similar experiments with a nordractionated 
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HeLa nuclear extract and NTera-2D1 nuclear extract, 
using wild-type and mutant octamer probes, showed 
that the CI complex is the only evident octamer-specific 
complex to form in these cell extracts and that all of the 
CI complexes are abolished by addition of the kC5 im- 
mune antiserum. These results suggest that there is only 
one major octamer-binding activity in these cells and 
that the oct-1 gene cloned in KC5 encodes this protein. 
Because the lymphoid-specific and ubiquitous oc- 
tamer-binding proteins bind the octamer motif indistin- 
guishably, we tested whether the DNA-binding domains 
of these two proteins might be antigenically related. 
Figure 4B shows that this is indeed the case. When im- 
mune antiserum is added to a BJAB nuclear extract, both 
ubiquitous (labeled NF-A1; Staudt et al. 1986) and lym- 
phoid-specific (NF-A2) octamer complex formation are 
inhibited (Fig. 4B, lane 3); but upon dilution of the im- 
mune serum, the octamer-specific complexes are re- 
stored. These results indicate that the Oct-1 and Oct-2 
proteins contain antigenically related DNA-binding do- 
mains. 
When the preimmune and immune kC5 antisera were 
used in a Westem blot of a HeLa cell nuclear extract, 
multiple species reacted, thereby preventing dentifica- 
tion of the Oct-1 protein. In an immunoprecipitation f 
a radiolabeled 293 cell extract, however, among the 
many species that were immunoprecipitated, the only 
obvious difference between the preimmune and immune 
antisera precipitations wa  a protein of -95 kD (data not 
shown). This molecular mass is consistent with the size 
of OTF-1 (Fletcher et al. 1987), NFIII (O'Neill and Kelly 
1988), and OBP100 (Sturm et al. 1987). 
Nucleotide sequence of oct-/ 
Figure 5A shows the 2584-nucleotide-long sequence of 
the oct-1 gene plus poly(A) sequence, as deduced from 
the KC5 insert and from a kgtl0 oct-1 cDNA clone (KC7) 
described below. The ~,C5 insert (2424 nucleotides long, 
excluding the EcoRI linkers) was sequenced in entirety 
on both strands and over all restriction sites by the 
chain-termination method (see Materials and methods). 
The nucleotide sequence of the ~C5 insert revealed an 
open reading frame, 762 amino acids long in-frame with 
the [3-galactosidase-coding sequences. To characterize 
the 5' and 3' ends of the oct-1 mRNA, we isolated 16 
independent kgtl0 clones from a separate NTera-2D1 
cDNA library (provided byJ. Skowronski; Skowronski et 
al. 1988), using the KC5 insert as the probe. Analysis of 
these cDNAs showed that they were either similar in 
size or shorter than the KC5 insert, suggesting that the 
kC5 insert is nearly full length. Nucleotide sequence 
analysis of the 5' and 3' termini of the longest ~,gtl0 
cDNA clone, kC7, extended the 5' oct-1 nucleotide se- 
quence by 9 bp and revealed the nucleotide sequence of 
the entire 3'-untranslated region. Not shown in Figure 
5A is the presence of an extra sequence in ~C7, 102 nu- 
cleotides long, located near the 5' end, which may re- 
flect alternative splicing. An extensive analysis of KC7 
and the other cDNAs will be described in a separate 
communication. 
Determination of the exact position of the 5' end of 
the oct-1 mRNA by primer extension and determination 
of mRNA size by Northern blotting have been hampered 
by a low abundance of oct-1 mRNA. The inability to ex- 
tend significantly the 5' sequence of KC5 by isolation of 
multiple cDNAs suggests that in KCS, the [3-galactosi- 
dase fusion is into the 5'-untranslated region of the oct-1 
mRNA. Therefore, we tentatively assign the first in- 
frame ATG codon (60 nucleotides downstream of the 
start of the oct-1 sequence shown in Fig. 5A) as the initi- 
ation codon for the oct-1 encoded protein Oct-1 and 
number both the nucleotide and amino acid sequence 
from this point. This assignment predicts that the Oct-1 
protein is 743 amino acids long with an estimated mo- 
lecular mass of 76 kD. However, as described below, the 
in vitro translation product from this cDNA has a con- 
siderably larger apparent molecular mass of between 90 
and 94 kD. 
The amino acid composition of the predicted Oct-1 
protein is enriched for glutamine (11%), serine (14%), 
threonine (10%), and proline (7%). Whereas the proline 
residues are rather evenly distributed throughout he 
Oct-1 protein, the glutamine residues are highly concen- 
trated within the amino-terminal third of the protein 
(26% from amino acid 22-268; see Fig. 5B). The entire 
protein is rich in serine and threonine residues, but the 
region from amino acid 441 to 560 is particularly Ser/ 
Thr rich, as 50% (60/120) of these residues are either 
serine or threonine. A high concentration and uneven 
distribution of glutamine, and serine and threonine res- 
idues is reminiscent of the ubiquitous mammalian tran- 
scription factor Spl (Kadonaga et al. 1987). Unlike Spl, 
however, the Oct-1 protein does not contain zinc finger 
motifs consistent with the Zn2+-independent DNA- 
binding activity of the ubiquitous octamer-binding pro- 
tein (Westin and Schaffner 1988). The central portion of
the oct-1 coding sequence is very rich in both basic and 
acidic amino acids. From residue 272 to 436, 18% 
(29/165) of the residues are either arginine or lysine and 
14% (23/165) are the acidic residues aspartic or glutamic 
acid. It is this 165-amino-acid-charged domain that con- 
tains the DNA-binding domain (see below). 
Amino acid sequence comparison between the Oct-1 
and Oct-2 proteins reveals a highly conserved omam 
One of our primary interests in cloning the ubiquitous 
octamer-binding protein is to understand how it shares 
the same DNA-binding specificity as the lymphoid-spe- 
cific octamer-binding protein but apparently differs in 
trans-activation function. Therefore, we compared the 
amino acid sequence of Oct-1 with the Oct-2 sequence 
determined by Clerc et al. (1988). As shown in Figure 
6A, the amino-terminal regions of the two proteins dis- 
play significant but patchy homology, in part reflecting 
the glutamine-rich composition of these two proteins 
within this region. The carboxy-terminal regions display 
only a few short regions of sequence similarity. Curi- 
ously, in Oct-2, these short sequence similarities are 
juxtaposed to create a leucine zipper motif (Landschulz 
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GAGGAGCAGCGAGTCAAGATGAGAGTTCAGCCGCGGCGG•AGCAGCAGCAGACTCAAGAATGAACAATCCGTCAGAAACCAGTAAACCATCTATGGAGAGTGGAGATGGCAACACAGGC 60 
~r--~erG~nAspG~u~er~erA~aA~aA~aA~aA~aA~aA~aAsp~erArgMET-----AsnAsn~r~erG~uThr~erLys~r~erMETG~u~erG~yAspG~AsnThrG~y 20 
~-gal-) l--lC5-) 
BstXI 
ACACAAACCAATGGTCTGGACTTTCAGAAGCAGCCTGTGCCTGTAGGAGGAGCAATCTCAACAGCCCAGGCGCAGGCTTT•CTTGGACATCTCCATCAGGTCCAACTCGCTGGAACAAGT 180 
ThrG•nThrAsnG•yLeuAspPheG•nLysG•nPr•Va•Pr•Va•G•yG•yA•aI•e•erThrA•aG•nA•aG•nA•aPheLeuG•yHisLeuHisG•nVa•G•nLeuA•aG•yThrSer 60 
~--Gln rich-9 
TTACAGGcTGCTGcTCAGTcTTTAAATGTACAGTCTAAATCTAATGAAGAATCGGGGGATTCGCAGCAGCCAAGCCAGCCTTcCCAGcAGCCTTCAGTGcAGG•AGCCATTCCCCAGACC 300 
LeuG•nA•aA•aA•aG•nSerLeuAsnVa•G•n•erLys•erAsnG•uG•u•erG•yAspSerG•nG•n•r•SerG•nPr•SerG•nG•nPr•SerVa•G•nA•aA•aI•e•r•G•nThr I00 
CAGCTTATGCTAGCTGGAGGACAGATAACTGGGCTTACTTTGACGCCTGCCCAGCAACAGTTACTACTCCAGCAGGCACAGGCACAGGCACAGCTGCTGGCTGCTGCAGTGCAGCAGCAC 420 
G•nLeuMETLeuA•aG•yG•yG•nI•eThrG•yLeuThrLeuThrPr•A•aG•nG•nG•nLeuLeuLeuG•nG•nA•aG•nA•aG•nA•aG•nLeuLeuA•aA•aA•ava•G•nG•nHis 140 
TCCGCCAGCCAGCAGCACAGTGCTGCTGGAGCCACCATCTCCGCCTCTGCTGCCACGCCCATGACGCAGATCCCCCTGTCTCAGCCCATACAGATCGCACAGGATCTTCAACAACTGCAA 540 
SerA•a•erG•nG•nHis•erA•aA•aG••A•aThrI•e•erA•a•erA•aA•aThr•r•METT•rG•nI•e•r•Leu•erG•nPr•I•eG•nI•eA•aG•nAspLeuG•nG•nLeuG•n 180 
~Gln rich--~ F--GIn rich-) 
CAGCTTCAACAGCAGAATCTCAACCTGCAACAGTTTGTGTTGGTGCATCCAACCACCAATTTGCAGCCAGCGCAGTTTATCATCTCACAGACGCCCCAGGGCCAGCAGGGTCTCCTGCAA 660 
G•nLeuG•nG•nG•nAsnLeuAsnLeuG•nG•n•heVa•LeuVa•His•r•ThrThrAsnLeuG•nPr•A•aG•nPheI•eI•eSerG•nThr•r•G•nG•yG•nG•nG•yLeuLeuG•n 220 
GCGCAAAATCTTCAAACGCAACTACCTCAGCAAAGCCAAGCCAACCTCCTACAGTCGCAGCCAAGCATCACCCTCACCTCCCAGCCAGCAACCCCAACACGCACAATAGCAGCAACCCCA 780 
A•aG•nAsnLeuG•nThrG•nLeu•r•G•nG•n•erG•nA•aAsnLeuLeuG•nSerG•n•r•SerI•eThrLeuThrSerG•nPr•A•aThrPr•ThrArqThrI•eA•aA•aThr•r• 260 
HincII 
, 
ATTCAGACACTTCCACAGAGCCAGTCAACACCAAAGCGAATTGATACTCCCAGCTTGGAGGAGCCCAGTGACCTTGAGGAGCTTGAGCAGTTTGCCAAGACCTTCAAACAAAGACGAATC 900 
I leGlnThrLeuProGlnSerGlnSerThrProLysArgI leAspThrProSerLeuG luGl uProSerAspLeuGluGluLeuGl uGlnPheAlaLysThrPheLysGl nArgArgI le 300 
~-Gln rich--~ ~--Acidic/Bas ic-) 
•AACTTGGATTCACTCAGGGTGATGTTGGGCTCGCTATGGGGAAACTATATGGAAATGA•TTCAGCCAAACTACCATCTCTCGATTTGAAGCCTTGAACCTCAGCTTTAAGAACATGTG• 1020 
LysLeuG•yPheThrG•nG•yAspVa•G•yLeuA•aMETG•yLysLeuTyrG•yAsnAsp•he•erG•nThrThrI•e•erArg•heG•uA•aLeuAsnLeuSer•heLysAsnMETCys 340 
EcoRI 
! | 
AAGTTGAAGCCACTTTTAGAGAAGTGGCTAAATGATGCAGAGAACCTCTCATCTGATTCGTCCCTCTCCAGCCCAAGTGCCCTGAATTCTCCAGGAATTGAGGGCTTGAGCCGTAGGAGG 1140 
LysLeuLysPr~LeuLeuG~uLysTrpLeuAsr~spA~aG~uAsnLeu~erSerAspSer~erLeuSerSer~r~SerA~aLeuAsnSer~r~G~yI~eG~uG~yLeuSerArgArgArg 380 
BclI ,,, 
l l 
AAGAAA•GCACCAGCATAGAGACCAACATCCGTGTGGCCTT•GAGAAGAGTTTCTTGGAGAATCAAAAGCCTACCTCGGAAGAGATCACTATGATTGCTGATCAGCTCAATATGGAAAAA 1260 
LysLysArgThrSerI•eG•uThrAsnI•eArgVa•A•aLeuG•uLysSerPheLeuG•uAsnG•nLysPr•ThrSerG•uG•uI•eThrMETI•eA•aAspG•nLeuAsnMETG•uLys 420 
PflMI 
| I 
GAGGTGATTCGTGTTTGGTTCTGTAACCGCCGCCAGAAAGAAAAAAGAATCAACCCACCAAGCAGTGGTGGGAC•AGCAGCTCACCTATTAAAGCAATTTTCCCCAGCCCAACTTCACTG 1380 
G•uVa•I•eArgVa•Trp•heCysAsnArgArgG•nLysG•uLysArgI•eAsn•r••r•SerSerG•yG•yThrSer•erSer•r•I•eLysA•aI•ePhePr•Ser•r•ThrSerLeu 460 
[ H . 1 (-Acidic/Basic--~ ~--Ser/Thr rich-) 
GTGGCGACCACACCAAGCCTTGTGACTAGCAGTGCAGCAACTACCCTCACAGTCAGCCCTGTCCTCCCTCTGACCAGTGCTGCTGTGACGAATCTTTCAGTTACAGGCACTTCAGACACC 1500 
Va•A•aThrThrPr•SerLeuVa•ThrSer•erA•aA•aThrThrLeuThrVa••erPr•Va•Leu•r•LeuThr•erA•aA•aVa•ThrAsnLeu•erVa•ThrG•yThrSerAspThr 500 
HaeII 
ACCTCC/~C/~CACAGCAACCGTGATTTCCACAGCGCCTCCAGCTTCCTCAGCAGTCACGTCCCCCTCTCTGAGTCCCTCCCCTTCTGCCTCAGCCTCCACCTCCGAGGCATCCAGTGCC 1620 
Thr•erAsnAsnThrA•aThrVaII•e•erThrA•a•r••r•A•a•er•erA•aVa1Thr•erPr••erLeu•er•r••erPr••erA1a•erA•a•erThr•erGIuA1a•er•erA1a 540 
AGTGAGACCAGCACAACACAGACCACCTCCACTCCTTTGT CCTCCCCTCTTGGGAC CAGCCAGGTGATGGTGACAGCATCAGGTTTGCAAACAGCAGCAGCTGC T C CTTCAAGGAGCT 1740 
SerGluThrSerThrThrGl nThrThrSerThrProLeuSerSerP roLeuGlyThrSerGl nVa IMETVal ThrAla SerGlyLeuGlnThrAlaAl aAlaAl aAlaLeuGlnGlyAla 580 
~-Ser/Thr rich--~ 
Figure 5. (See following page for legend.) 
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Sturm et al. 
et al. 1988a; Clerc et al. 1988) that is not present in 
Oct-1. 
The most striking region of similarity between Oct-1 
and Oct-2 lies within the centrally located 160-amino- 
acid-long highly charged omain extending from residue 
280 to residue 439 in Oct-1 [Oct-2 has three additional 
residues). In this region, these two proteins share iden- 
tical residues at 142/160 positions. This represents 89% 
sequence similarity. The amino-terminal half of this 
conserved omain displays the highest degree of simi- 
larity; 74 out of 75 residues are identical. The amino-ter- 
minal portion of these 75 residues contains the sequence 
PSDLEELE, which is a consensus casein kinase II (CKII) 
phosphorylation site (Kuenzel et al. 1987), and there is a 
second adjacent potential CKII phosphorylation site 
(PSLEE in Oct- l ) just  upstream. The central portion of
the shared charged domain is less related, displaying 
~50% identity (14 out of 24 positions in Oct-l). The re- 
mainder of the charged domain (residues 378-439) is 
89% identical. This latter region contains a putative 
helix-turn-helix motif, characteristic of many DNA- 
binding proteins (Pabo and Saner 1984), and is distantly 
but significantly related to the homeo box motif first 
identified in Drosophila homeotic genes (McGinnis et 
al. 1984; Scott and Weiner 1984). 
Figure 6B shows a sequence comparison between the 
Ncol 
, l 
G~A~AGTTGCCAG~A1~TGCCAGTCTTGCTG~CATGGCAGCTGCTGCAGGACT1~a~.C~G~TGATGGCAC~TCACAGTTTGCGGCTGGAGGTGCCTTACTCAGTCTG~d%T~CAGGG 1860 
A~aGlnLeu~r~A~aAsnAla~erLeuA~aAIa~ETA~aA~aA1aAIaG~yLeuAsnPr~erLeu~ETA~aPr~erGIn~heA~aAIaG~yG~yA~aLeuLeu~erLeuAsnPr~G~y 620 
ACCCTGAGCGGTGCTCTCAGCCCAGCTCTAATGAGCAACAGTACACTGGCAACTATTCAAGCTCTTGCTTCTGGTGGCTCTCTTCCAATAACATCACTTGATGCAACTGGGAACCTGGTA 1980 
ThrLeuSerG•yA•aLeuSerPr•A•aLeuMETSerAsnSerThrLeuA•aThrI•eG•nA•aLeuA•aSerG•yG•ySerLeuPr•I•eThrSerLeuAsDA•aThrG•yAsnLeuVa• 660 
TTTGCCAATGCGGGAGGAGCCCCCAACATCGTGACTGCCCCTCTGTTCCTGAACCCTCAGAACCTCTCTCTGCTCACCAGCAACCCTGTTAGCTTGGTCTCTGCCGCCGCAGCATCTGCA 2100 
PheA•aAsnA•aG•yG•yA•aPr•AsnI•eVa•ThrA•a•r•LeuPheLeuAsnPr•G•nAsnLeuSerLeuLeuThrSerAsnPr•Va•SerLeuVa•SerA•aA•aA•aA•aSerA•a 700 
GGGAACTCTGCAc•TGTAGcCAGCCTTCACGCCACCTCCACCTCTGCTGAGTCCATCCAGAA•TCTCT•TTCA•AGTGGCCTCTGCCAG•GGGGCTGCGTCCACCACCA•CACCGCCTCC 2220 
G•yAsnSerA•aPr•Va•A•aSerLeuHisA•aThrSerThrSerA•aG•uSerI•eG•nAsnSerLeuPheThrVa•A•aSerA•a•erG•yA•aA•a•erThrThrThrThrA•aSer 740 
Poly A 
AAGGCACAGTGAGCTGGGCAGAGcTGGGCTGCCAGAAGCCTTTTTCACTCTGCAGTGTGATTGGACTGCCAGCCAGGTTAATAAACTGAAAAATGTGATTGGCTTCCTCTCGCCGTGTTG 2340 
LysAlaGln*** 743 
Poly A 
TGAGGGCAAAGGAGAGAAGGGAGA.~-~J~-~%AA~AcA~ACAcc~ATAcAcAcATAcCAGAAAAAGAAAGAAAGGATGGAGAcGGAA~ATTTGcCTAATTTTGTAATAAAACA~T 2460 
<-kc5-~ 
GTCTTTTCAGGATTGCTTCATGGATTGGAGAACTTTCTAACCAAAAATTAAA~ 2525 
I I00 200 500 400  500 
Gin-rich Acidic/Bosic Ser/Thr- rich 
~; ::::::::::::::::::::::::::::::::::::::::::::::::::::: ~, ~ i::i::i::i!!::ii!i:.!::i::iii::i!iliiiiiii':ili':i~::i:: 
600 700 o.o. 
! i 
COOH 
I 
Figure 5. Nucleotide sequence of human oct-1 and deduced amino acid sequence of the Oct-1 protein. (A) The DNA sequence and 
deduced amino acid sequence of the oct-1 gene derived from the hC5 clone and the overlapping kC7 clone. The numbering system 
shown at the right of the sequence begins for both nucleotide and peptide sequences atthe putative initiation codon ATG (labeled 1
over the underlined MET; Kozak 1984). The position of the fusion of oct-1 to 13-galactosidase in hC5 is indicated, and the extra proline 
residue ncoded by the EcoRI linker oct-1 junction sequence is underlined; the 3' end of the hC5 clone is also indicated. Glutamine, 
acidic/basic, and serine/threonine-rich egions, discussed in the text, are bounded by arrows. The position of restriction enzymes used 
in the mapping of the oct-1 DNA binding-domain are highlighted on the sequence, and the helix-turn-helix motif is represented below 
the amino acid sequence by the two boxes (helixes) joined by the line (turn). The position of two consensus polyadenylation hexamers, 
AATAAA, is also indicated. (B) A schematic llustration of the structure of the deduced 743-amino-acid reading frame of the Oct-1 
protein beginning at the predicted initiator MET (amino acid 1 in A). The regions outlined by arrows in A are boxed and shaded in B. 
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Oct - i  
Oct -2  
Oct - i  
Oct -2  
Oct - i  
Oct -2  
Oct - i  
Oct -2  
Oct - i  
Oct -2  
Oct - i  
Oct -2  
Oct - i  
• . , • • . • ** • • . ****  . . ** • **  ****  . . 
MNNPSET•KP•MESGDGNTGTQTNGLDFQKQP•P•GGAI•TAQAQAFLGHLHQ•QLAGTSLQAAAQSLNvQ•KSNEESGDSQQPSQP-SQQP•VQAAIPQTQLMLAGGQ 108 
MVHSSMGAPEIRMSKPLEAEKQGLDSPSEHTDTERNGPDTNHQNPQNKT . . . . . . . . . . . . . . . . . . . . .  SPFSVSPTGPSTKIKAEDPSGDSA-PAAPLPPQPA-QPHLPQAQLMLTGSQ 98 
* , *** * ***  ***  ****  , * * ***  **  ***  
ITGLTLTPAQQQLLLQQAQAQAQLLAAAVQQHSA•QQH•AAGATISASAATPMTQIPLSQPIQ IAQDLQQLQQLQQQNLNLQQFVL•HPTTNLQPAQFI I•QT•QGQQGLLQAQNLQTQL• 229 
LAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  D IQQL . . . . . . .  LQLQQLVLVPGHHLQPPAQFLLPQAQQSQPGLLPTPNL-FQLP  148 
**  , * *  ***  . . ** • ** , *************  *********************************************************  
QQSQANLLQSQP S ITLTSQPATPTRTIAATP IQTLP  QSQS TP  KR I  DTP  S LEEP  S DLEELEQFAKTFKQR/ t  IKLGFTQGDVGLAMGKLYGNDFSQTT I SRFEALNLSFKNMCKLKP LLEKWL 350 
QQTQGALLTSQPRAGLPTQ- -AVTRPTLPDPHLSHPQPPKCLEP PSHP- -  EEP  SDLEELEQFARTFKQRRIKLGFTQGDVGLAMGKLYGNDFSQTT I SRFEALNLS F KNMCKLKPLLEKWL 265 
< POU-SPECIF IC  BOX"  
****  , * ***  **  , * *  , * *  ************  , * ******  *********  **  **  **********************  , * **  * • 
NDAENL••D•SLSSPSALNSP- -G IEGL-SRRRKKRT• IETNIRVALEKSFLENQKPT•EE ITMIADQLNMEKEVIRVWFCNRRQKEKRINPPSSGGTSSSP IKA IFPSPTSLvATTP•LV 468 
NDAETMSVDSSLPSPNQLSSPSLGFDGLPGRRRKKRTSIETNvRFALEKSFLANQKPTSEEILL IAEQLHMEKEVIRVwFCNRRQKEKRINPC•AA . . . . . . . .  PMLPSPGKPASYSPHMV 378 
< POU HOMEO BOX 
• ***  • , ***  **  * ***  **  * * . * 
TSSAATTLTVSPVLPLTSAAVTNLSVTGTSDTTSNNTATVISTAPPAS•AVTSPSLSPSPSASASTSEA•SA•ETSTTQTTSTPLSSPLGTSQVMvTASGLQTAAAAALQGAAQLPANASL 589 
TPQGGAG . . . . .  TLPLSQA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  SSSLS  . . . . . . . . . . . . . . . . . . . . . .  TTVTTLSSAVGT . . . . . . . . .  LHPSRTAGGGGGGGGAAPPLN 430 
AAMAAAAGLNP•LMAPSQFAAGGALLSLNPGTLSGALSPALM•NSTLAT IQALASGGSLP ITSLDATGNLVFANAGGAPNIVTAPLFLNPQNLSLLTSNPVSLVSAAAA•AGNSAPVASLH 710 
S IPSVTPPPPATTNSTNPSPQGSHSAIGLSGLNPSTG 467 
ATSTSAESIQNSLFTVASASGAASTTTTASKAQ 743 
B. 
Homeo Box  
Consensus  
Oct  1 
Oct  2 
Unc  86 
Eve 
Antp  
En  
xx /Oct -  1 
1 H . ~----T------~ H • 
. . . .  R - - Y - - - Q - - - L - - - F . . . .  y . . . . .  R - - - A - - L - L - - - Q -  K I W F Q N R R -  K - K - - -  12 /60  
J 1 L 1 [ 1 1 L 1 1 1 f 
R R K K R T S I E T N I R V A L E K S F L E N Q K P T S E E I T M I A D Q L N M E K E V I R V W F C N R R Q K E K R I N  60/60  
. . . . . . . . . . .  V . F . . . . . . .  A . . . . . . . . .  L L . . E . . H . . . . . . . . . . . . . . . . . . . . .  53 /60  
K K R  . . . . .  A A P E K R E . . Q F ~ K Q Q P R . S G . R . A S . . . R . D L K . N . V  . . . . . .  Q . . . Q , . D F  28 /60  
V . R Y . . A F T R D Q L G R . . . E . Y K E N Y V S R P R R C E L . A , . . L P E S T . K . , . Q . . . M . D . . Q R  21/60  
K R G . Q T Y T R Y Q T L E . . . E , H F . R Y L . R R R R I E . , H A . C L T E R Q . K I . . Q . . . M . W , K E .  20 /60  
E K R P . . A F S S E Q L A R . K R E . N . . R Y L . E R R R Q Q L S S E . G L N E A Q . K I . . Q H K . A . I . K S T  14/60  
Figure 6. Sequence homology between Oct-1 and the lymphoid-specific octamer-binding protein Oct-2 and comparison between the 
Oct-1 homeo box domain and both prototypic Drosophila homeo box domains and the C. elegans unc-86 gene product (Finney et al. 
1988). (A) The Oct-1 and Oct-2 protein sequences are shown in the one-letter code and have been aligned for maximum homology. 
Positions of identity between the two sequences are indicated by the asterisks (*) above the sequence, and the POU-specific and 
POU-related homeo box domains are shown below the sequence. {B} The amino acid sequence of the Oct-1 homeo box region is 
compared with Oct-2 (Clerc et al. 1988), unc-86 [Finney et al. 1988), eve (Macdonald et al. 1986), Antp [Schneuwly et al. 1986), and en 
(Poole et al. 1985) homeo box domains. The dots below the Oct-1 sequence represent positions of identity. A homeo box consensus 
sequence (Scott et al. 1989) is shown for comparison above the Oct-1 sequence. The position of variable amino acids in the consensus 
sequence is shown by dashes, and those conserved residues aligning with the Oct-1 sequence are indicated by the vertical lines. The 
number of residues hared with the Oct-1 sequence in the 60-amino-acid homeo box region is tabulated to the right of each sequence. 
homeo box region of Oct-1 and Oct-2 and the homeo box 
region of three different prototypic Drosophila homeo 
box proteins: even-skipped (eve), Antennapedia (Antp), 
and engrafted (en} and the recently described C. elegans 
tmc-86 cell lineage gene product (Finney et al. 1988). 
Also included is a homeo box consensus equence devel- 
oped by Scott et al. (1989), after comparing 83 different 
homeo box motifs (including Oct-l). The Oct-1 homeo 
box domain shares identity with the homeo box do- 
mains of Eve, Antp, and En at 21/60, 20/60, and 14/60 
positions, respectively. This region of Oct-1 also shares 
11 out of the 21 highly conserved residues established in 
the homeo box consensus sequence. Although the se- 
quence relationship is concentrated in the carboxy-ter- 
minal third of the domain, within and adjacent to the 
putative DNA recognition helix of the helix-turn-helix 
motif, there are four significant sequence identities out- 
side of this region (see Fig. 6B). 
Comparison of the Oct-1 and Oct-2 homeo-box-re- 
lated domains to the homeo-box-related omain in the 
tmc-86 gene product (Finney et al. 1988} shows a consid- 
erably higher level of homology between one another 
(28/60 between Oct-1 and nnc-861 than with the other 
homeo box proteins. The homeo box domain described 
in the pituitary-specific transcription factor Pit-1 (In- 
graham et al. 1988) is also closely related to the Oct-1 
homeo box. These results indicate that Pit-l, Oct-l, 
Oct-2, and tmc-86 form a related family. Surprisingly, 
this same family is even more related to one another 
within the 75-amino-acid region that is nearly identical 
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between Oct-1 and Oct-2 {see Herr et al. 1988 and dis- 
cussion below). Because the entire 160-amino-acid-long 
charged region is conserved among these four proteins, 
we refer to it as the POU (Pit-l, Oct-1 and Oct-2, and 
_unc-86)-related domain (pronounced 'pow'). 
The Oct-1 DNA-binding domain lies within the highly 
conserved PO U domain 
To map the Oct-1 DNA-binding domain, we used in 
vitro-translated Oct-1 protein in gel retardation assays, 
as first described by Hope and Struhl (1985). The entire 
hC5 insert was cloned into the BlueScript vector [pBS 
M13+; Stratagene), which carries opposing T3 and T7 
bacteriophage RNA polymerase promoters. To produce 
full-length Oct-1 protein and mutant derivatives, sense 
oct-1 RNA was transcribed in vitro with T7 RNA poly- 
merase and the RNA translated in an in vitro rabbit re- 
ticulocyte translation system. The expression construct 
was designed so that the first AUG codon in the in vitro 
transcribed RNA is the first ATG in the hC5 insert {la- 
beled nucleotide 1 in Fig. 5A). The in vitro-translated 
proteins were analyzed by polyacrylamide gel electro- 
phoresis and subsequently used in a gel retardation assay 
with radiolabeled wild-type and mutant octamer-con- 
taining DNA fragments. The largest oct-1 in vitro trans- 
lation product has an apparent molecular mass of about 
90-94 kD, considerably arger than the predicted 76 kD 
of the 743-amino-acid-long hC5-encoded protein but, 
nevertheless, -2 -5  kD smaller than purified HeLa cell 
octamer-binding protein (data not shown). This differ- 
ence could reflect usage of the wrong initiation codon or 
lack of appropriate modifications. 
Figure 7A shows the different deletions that were 
tested for DNA-binding activity in a gel retardation 
assay. Figure 7B shows a gel retardation assay with the 
Oct-1 carboxy-terminal deletions. In each case, the pro- 
teins were mixed with labeled DNA fragments con- 
taining the wild-type SV40 octamer motif (odd-num- 
bered lanes) or the double point mutant dpm8 (even- 
numbered lanes}. Authentic HeLa cell octamer-binding 
protein was used as a marker [lanes 1 and 2). Addition of 
the rabbit reticulocyte xtract itself {lanes 3 and 4) pro- 
duced a weak endogenous octamer-binding activity that 
is not visible on the exposure shown. The full-length in 
vitro translation product produced a gel retardation 
complex with a slightly greater mobility than the au- 
thentic HeLa cell octamer-binding protein (cf. lanes 1 
and 5), consistent with the somewhat smaller apparent 
molecular weight of the in vitro translated product. The 
largest carboxy-terminal truncation that still retained 
octamer-specific DNA-binding activity mapped to the 
carboxyl terminus of the homeo box domain {PflMI site 
at amino acid 440; see Fig. 5A) (cf. lanes 11 and 12). 
Truncation of an additional 26 residues removed the 
'recognition' helix of the helix-turn-helix motif and 
abolished DNA-binding activity {BclI, lane 13), as did re- 
moval of the entire POU domain (HincII, lane 15). This 
result shows that the homeo box motif is required for 
DNA binding, whereas the sequences carboxy terminal 
to the homeo box are dispensable. 
To determine whether the entire conserved POU do- 
main is sufficient for DNA binding, we deleted the 
amino-terminal domain from residue 23 to 270, just 19 
residues upstream of the POU domain (see Figs. 5A and 
7A). By retaining the same 5'-untranslated region plus 
70 nucleotides of coding sequence, we decreased the 
likelihood of a change in initiation codon usage during 
the in vitro translation. Figure 7C shows the effect of 
this amino-terminal deletion. Either with (HindIII; lanes 
3 and 4) or without (PflMI; lanes 5 and 6) the sequences 
downstream of the homeo box domain, this amino-ter- 
minal deletion still binds specifically to the octamer 
motif. These results indicate that the POU-conserved 
domain is sufficient for DNA sequence recognition, al- 
though we cannot preclude that the amino-terminal 23 
residues are not also required. 
Discuss ion  
We have described the isolation and characterization f 
human oct-1 cDNA clones encoding the ubiquitously 
expressed octamer-motif-binding protein Oct-1. This 
gene probably encodes the HeLa cell octamer-binding 
protein that has been isolated and named differently by 
several groups, i.e., OTF-1 [Fletcher et al. 1987), NFIII 
Figure 7. Deletion mapping of the Oct-1 octamer-motif-binding domain. (A) A schematic llustration of the structure of the oct-1 
protein product produced by in vitro translation ofmRNA templates produced from pBSoct-1 +. The 743-amino-acid reading frame is 
boxed, and the glutamine, acidic/basic, and serine/threonine-rich egions described in Fig. 5, are shaded. The truncations and internal 
deletion used to map the DNA-binding region f the protein are outlined below the schematic figure, and the corresponding restriction 
enzymes and DNA-binding activity are listed on the right. The region sufficient for binding activity is indicated by the arrow. The 
positions of the POU domain and the POU-specific and homeo-related boxes are shown at the bottom. (B) The gel retardation assay 
was performed with the B20 end-labeled EcoRI-PstI restriction fragments from pUCll9 containing the wild-type SV40 OBP100- 
binding site 1 (odd-numbered lanes} or with the dpm8 mutations (even-numbered lanes]. (Lanes 1, 2) Partially fractionated HeLa cell 
OBP100 as a marker; {lanes 3, el) no RNA added to the rabbit reticulocyte in vitro translation system as a negative control; (lanes 5, 6) 
full-length Oct-1 in vitro translation product generated from HindlII-digested pBSoct-1 +. Truncations were with restriction enzymes 
as follows: {lanes 7, 8)NcoI; (lanes 9, 10) HaelI; (lanes 11, 12)PflMI; (lanes 13, 14) BclI; (lanes 15, 16) HinclI. {C) The gel retardation 
assay was performed as in B: (lanes 1, 2) full-length Oct-1 in vitro translation product; (lanes 3, 4) the BstXI-HincII amino-terminal 
deletion of pBSoct-1 ÷; (lanes 5, 6) the PflMI truncation of the BstXI-HincII amino-terminal deletion. 
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(Pruijn et al. 1986; O'Neill and Kelly 1988), and OBP100 
{Sturm et al. 1987). The arguments in favor of this inter- 
pretation are severalfold. First, the cloned octamer- 
binding protein has the same flexible DNA-binding 
specificity as HeLa cell Oct-1 protein. Second, the oct-1 
gene is expressed in all of the five human and two mouse 
cell lines we examined and is thus expressed ubiqui- 
tously. Third, polyclonal rabbit antiserum raised against 
the cloned kC5 gene product shows an antigenic rela- 
tionship between the ubiquitous octamer-binding pro- 
tein and the ubiquitously expressed oct-1 gene. Fourth, 
the oct-1 in vitro translation product is nearly the same 
size as the authentic HeLa cell octamer-binding protein 
(see the similarly sized complexes formed in Fig. 7). 
Thus, oct-1 apparently encodes both a transcription 
factor (OTF-1) and an adenovirus replication factor 
(NHII) (O'Neill et al. 1988), in a manner similar to CTF/ 
NH (Santoro et al. 1988). 
We do not know, however, whether the actual poly- 
peptide encoded by the kC5 clone can activate either 
transcription or replication, or both. Multiple Oct-1 
species may exist that are of similar size but are gener- 
ated by alternative splicing of the primary oct-1 tran- 
script, and these may have different functions (e.g., acti- 
vation of different promoters). Different CTF/NH poly- 
peptides encoded by alternatively spliced mRNAs have 
already been described, and these polypeptides have dif- 
ferent ranscription and replication activities (Santoro et 
al. 1988). In vivo expression studies of the Oct-1 protein 
from the cloned gene have been hampered by the ubiqui- 
tous endogenous expression of this protein. Neverthe- 
less, if the Oct-1 protein encoded by the KC5 cDNA is 
coexpressed with a U2 snRNA promoter containing 
multimerized octamer motifs (see Tanaka et al. 1988), 
U2 transcription is weakly activated (M. Tanaka, N. 
Hemandez, and W. Herr, unpubl.). We are presently ana- 
lyzing more oct-1 cDNA clones to determine whether 
the oct-1 transcript is alternatively spliced and to per- 
form a functional analysis of the Oct-1 protein. 
Oct-1 and Oct-2 share highly related DNA-binding 
domains 
One of the major interests in determining the structure 
of the ubiquitous and lymphoid-specific octamer- 
binding proteins is to compare two proteins that bind to 
DNA with indistinguishable sequence specificity, but 
display different pattems of transcriptional ctivation. 
The amino acid sequence comparison shown in Figure 
6A and the mapping of the DNA-binding domain of 
these two proteins (Fig. 7; Clerc et al. 1988) show that 
the regions responsible for octamer-specific DNA 
binding are very closely related. We do not know which 
regions are responsible for the trans-activation activities 
of these two proteins, but the different activities of the 
octamer motif in cell-specific, compared with ubiqui- 
tously expressed, promoters uggest hat the regions of 
nonsimilarity between Oct-1 and Oct-2 are responsible 
for trans-activation. For example, the highly acidic do- 
main (EEPSDLEELE; residues 280-289 in Oct-I) shared 
between Oct-1 and Oct-2 is probably not sufficient for 
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activation of mRNA promoters because the octamer 
motif does not activate such promoters in the presence 
of Oct-1 {e.g., HeLa cells}. This acidic domain is also 
probably not directly involved in activation of snRNA 
promoters by Oct-1 because an acidic GAL4 transactiva- 
tion domain does not activate a U2 snRNA promoter 
containing GAL4 DNA-binding sites (Tanaka et al. 
1988). The region of highest divergence between Oct-1 
and Oct-2 is within the carboxy-terminal domain, in 
which the Oct-2 protein contains a leucine zipper motif 
(Landschulz et al. 1988a; Clerc et al. 1988}. Perhaps this 
motif permits specific protein-protein teractions that 
corder activation of mRNA-encoding promoters. 
The high degree of amino acid sequence similarity 
within the DNA-binding domains of Oct-1 and Oct-2 
suggests that the oct-1 and oct-2 genes arose by duplica- 
tion of a common ancestral gene. This high degree of 
amino acid sequence conservation appears to have been 
selected for strongly during evolution because compar- 
ison of the oct-1 and oct-2 (Clerc et al. 1988} nucleotide 
sequences encoding the 75-amino-acid-long region of 
highest identity (the POU-specific box) shows that 52% 
of the silent coding positions differ at the nucleotide 
level. This represents very little sequence conservation 
at these positions, strongly arguing that the similar 
amino acid sequences have been selected for at the level 
of the protein. What selective pressure may have main- 
tained this remarkable degree of amino acid sequence 
conservation within the POU domain? Because these 
proteins bind indistinguishably to the same DNA se- 
quences (Staudt et al. 1986}, a clear possibility is that the 
entire region is conserved to maintain the same DNA- 
binding specificity. Pit-1 represents he other member of 
the POU family for which the DNA-binding site has 
been well characterized {Nelson et al. 1988}. Curiously, 
this protein, in which the POU domain is less closely 
related to Oct-1 and Oct-2 than Oct-1 and Oct-2 are to 
themselves ( ee Herr et al. 1988), binds to a different, yet 
related, sequence motif (ATGNATA^/TA/TT, compared 
with ATGCAAAT; Nelson et al. 1988). These compar- 
isons suggest that the POU domain as a whole may bind 
to a similar class of DNA-binding sites and, conversely, 
that at least some of the differences between the Oct and 
Pit-1 POU domains are responsible for the differences in 
DNA sequence recognition. 
One of the surprising results in the analysis of the 
Pit-1 (Nelson et al. 1988} and Oct-1 (OBP100; 
Baumruker et al. 1988} DNA-binding specificities is that 
the individual proteins can bind to very dissimilar DNA 
sequences. We have shown that Oct-1 protein can bind 
to sequences that are identical at only 4 out of 14 posi- 
tions {AGTATGC~GCAT and GGCATCTCAT-_ 
TACC); nevertheless, imple point mutations within 
Oct-1 DNA-binding sites can abolish Oct-1 DNA 
binding. Therefore, Oct-1 exhibits a flexible, yet specific, 
pattern of DNA-binding site selection. This pattem of 
diverse sequence recognition is also exhibited by the 
Drosophila eve-encoded homeo box protein (Hoey and 
Levine 1988}. In the case of eve, Hoey et al. (1988} have 
shown that the protein context of the homeo box is im- 
portant in defining the relaxed binding specificity of the 
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Eve protein. In our studies, we have shown that the 
Oct-1 homeo box domain is essential for DNA-binding 
activity (Fig. 7). By analogy to Eve, the POU-specific box 
that flanks the homeo box domain in Oct-1 may reflect a 
highly conserved protein context that allows a POU 
class of homeo box domains to bind to a specific yet de- 
generate set of DNA-binding sites. Altematively, the 
POU domain may not be involved in DNA binding but, 
rather, may be responsible for interaction with other 
proteins involved in transcription. At present, we favor 
the involvement of the POU-specific box in DNA 
binding because of the correlation between the degree of 
similarity in DNA-binding specificity and the degree 
of similarity in POU domain sequence among the Oct-i, 
Oct-2, and Pit-1 proteins. 
The POU family of proteins represents a new class of 
homeo box proteins with ubiquitous and cell-specific 
m em b ers 
The majority of vertebrate homeo box genes have been 
cloned by cross-hybridization to either Drosophila or 
other vertebrate homeo box domains (for review, see 
Dressler and Gruss 1988), whereas the POU homeo box 
proteins were identified by either biochemical (Oct-l, 
Oct-2, and Pit-l) or genetic (unc-86) assays. Now that 
this new family of homeo box proteins has been identi- 
fied, hybridization studies with sequences from the POU 
domain may uncover more members of this class of 
homeo box proteins. The identification of both cell-spe- 
cific and ubiquitously expressed transcription factors, 
along with a C. elegans gene product involved in regu- 
lating cell fate, affords a new perspective on homeo box 
proteins and the POU domain. The presence of well- 
characterized transcription factors in this class shows 
that homeo box proteins can be positive activators of 
gene expression. The cell-specific members show that 
these trans-activators can determine cellular differentia- 
tion and cell lineage (Clerc et al. 1988; Finney et al. 
1988; Ingraham et al. 1988). The Oct-1 protein is unique 
in that it is a transcription (and DNA replication) factor 
with a homeo box domain that is ubiquitously expressed 
in different cell types. This result suggests that the 
homeo box is one of several possible DNA-binding 
motifs (like zinc fingers) that is used by both general and 
cell-specific transcription factors to regulate gene ex- 
pression by sequence-specific DNA binding. 
Materials and methods 
Isolation of hC5 from an NTera-2D1 kgtll cDNA library 
An amplified hgtl 1 library made from cytoplasmic polyadenyl- 
ated RNA of NTera-2D1 human teratocarcinoma cells, using 
oligo(dT) primer (SenGupta et al. 1986), was screened by the in 
situ filter detection method of Vinson et al. (1988). Recombi- 
nant phage at 4 x l0 s were screened at a density of 2 x 104 per 
filter after lytic infection of E. coli strain Y1090 (Young and 
Davis 1983). The probe used in screening the filters was pre- 
pared by nick-translation (Maniatis et al. 1982) of purified 
14 x B17 HindIII-PstI restriction fragment (Ondek et al. 1987), 
which contains 14 reiterated copies of SV40 Octal motif (Sturm 
Molecular cloning of ct-1 
et al. 1987). One positive plaque, named hC5, bound the 
14xB17 probe in duplicate with high affinity and was subse- 
quently purified by three rounds of plaque purification (Man- 
iatis et al. 1982) using the same in situ binding procedure. Bac- 
teriophage L20 encoding the DNA-binding domain of C/EBP 
linked to [3-galactosidase (Landshulz et al. 1988b) was used as a 
negative control for nonspecific binding of the radiolabeled 
14xB17 probe to hgtll recombinant plaques, and a C/EBP- 
binding site probe {Vinson et al. 1988) was used to test the se- 
quence-specificity of KC5 DNA binding. 
Production of fLgalactosidase fusion protein, Southwestern 
blotting, and gel retardation analysis 
Phage stocks of hgtl 1, L20, and hC5 were prepared from plate 
lysates of Y1090 (Maniatis et al. 1982) and used to infect a cul- 
ture of Y1089 (Young and Davis 1983) in log-phase growth. An 
overnight culture of Y1089 was diluted 1 : 50 in phage broth 
(L-broth, 10 mM Tris-HC1 at pH 7.5, 10 mM MgSO4) and grown 
for 1 hr; the cells were pelleted by centrifugation and resus- 
pended in 0.2 volumes of flesh broth. Infections were done at an 
estimated moi of 5 for 10 min at room temperature, after which 
two volumes of phage broth prewarmed to 45°C was added and 
the culture grown for 10 min at 42°C. Synthesis of the [3-galac- 
tosidase fusion protein was induced subsequently by addition 
of IPTG to 10 mM and incubation at 37°C for 1-2 hr before the 
cells were collected by centrifugation. 
When total protein synthesis was examined, the cells were 
resuspended in SDS-loading buffer and heated to 90°C for 10 
min before sample loading onto SDS-polyacrylamide g ls. For 
Southwestern blot analysis, the proteins resolved on SDS-poly- 
acrylamide gels were transferred electrophoretically from the 
gel to nitrocellulose at 100 mA for 12 hr in 25 mM Tris/190 mM 
glycine. The filters were then probed according to the protocol 
of Miskimins et al. (1985), using the same probe and buffer 
system used to screen the kgtl 1 recombinant phage filters (see 
above; Vinson et al. 1988). 
For gel retardation analysis, hC5-infected extract was pre- 
pared from the cell pellet by first resuspending and repelleting 
the cells in 1 ml of ice-cold 50 mM Tris-HC1 (pH 7.4), and 5 
EDTA, followed by resuspension i 1 ml of 50 mM Tris-HC1 
(pH 7.4), 200 rn~ NaC1, 1 rn/vi EDTA, 1 m~ dithiothreitol 
(DTT), 0.1% NP-40, 10% glycerol, 5 M urea, and cell lysis by 
sonication. Insoluble material was removed by a 10-rain Eppen- 
doff centrifugation, and the supernatant was dialyzed against 
50 mJvi Tris-HC1, 150 mM NaC1, 1 ~ EDTA, 1 mlvi DTT, 0.1% 
NP-40, and 10% glycerol to allow renaturation ofDNA-binding 
activity. The HeLa cell heparin/agarose-fractionated extract 
was the same as that described previously (Sturm et al. 1987). A 
nuclear extract (Dignam et al. 1983) prepared from the BJAB 
lymphoma cell line was the source of NF-A2 gel shifting ac- 
tivity (Staudt et al. 1986). The H9 T-lymphoma cell heparin- 
agarose fraction enriched for SRF was a gift from Dr. W. Ryan. 
Gel retardation analysis was performed as described previously 
(Sturm et al. 1987), with the modification of preincubating the 
extract with the binding mix for 10 min before addition of ra- 
diolabeled probe. 
The probes for gel retardation were 3' a2P-end-labeled restric- 
tion fragments obtained from the following plasmids: 
pUC119CoreA/CoreA- (CoreA probe), pUCll9B20wt + (SV40 
site I Octal probe), and pUCllgB2Odpm8 + (SV40 site I dpm8 
probe). These plasmids were constructed by ligation into the 
Sinai site of pUC119 end-filled 28-bp XhoI-digested monomer 
fragments isolated from the plasmids pf~6xCoreA/CoreA, 
p[36xB20 (SphII-SphI; Ondek et al. 1988), and pf36xB20dpm8 
(Tanaka et al. 1988). These fragments were resected for end-la- 
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beling as EcoRI-PstI fragments. The IgH enhancer probe was a 
HindIII-PstI fragment from pl3IgH + (Sturm et al. 1987), the 
TAATGARAT probe was an EcoRI-PstI fragment from cloned 
synthetic oligomers in pUG119 (Baumruker et al. 1988), and the 
SRE probe was an EcoRI-HindIII fragment from pUC119 con- 
taining a synthetic SRE site cloned into the HincII site (Gilman 
19881. 
Cell culture, RNA preparation, and RNase protection 
The NTera-2D1, WI-38, and BJAB cells were obtained from P. 
Andrews (Wistar Institute), E. Moran (Cold Spring Harbor Labo- 
ratory), and P. Sharp (MIT), respectively. NTera-2D1, WI-38, 
HeLa, 293, NS-1, and NIH/3T3 cells were grown in 10% fetal 
bovine serum in Dulbecco's modified Eagle's minimal medium 
with 100 U/ml penicillin and 100/xg/ml streptomycin. BJAB 
cells were grown in 10% fetal bovine serum in RPMI medium 
suplemented with 50 IxM mercaptoethanol. Spinner HeLa cells 
were grown to a density of 4 x l0 s cells/ml in 5% calf serum. 
Cytoplasmic RNAs were prepared by NP-40 lysis, as described 
previously (Shepard et al. 1988), except hat the DNase I diges- 
tion step was not included. The T3 RNA polymerase antisense 
oct-1 probe was prepared from a HaeIII-digested subclone of the 
5' 1.1-kb KC5 EcoRI fragment into the EcoRI site of pBSM13 + 
(Stratagene) (called pBSKC51.1+), generating a probe that 
spanned from nucleotide 642 to 1109 in the oct-1 sequence 
shown in Figure 5A. The probe was labeled with [a-a2p]CTP at 
400 Gi/mmole and purified by polyacrylamide g l electropho- 
resis. The probe was hybridized overnight to the different cyto- 
plasmic RNAs treated with RNase A and T1, and fractionated 
on 6% denaturing polyacrylamide g ls, as described previously 
(Zirm et al. 1983). 
Generation and use of rabbit anti-Oct-1 antisera 
KC5 fusion protein expressed in Y1089, as described above, was 
purified for use as antigen by preparative SDS-polyacrylamide 
gel electrophoresis of the total protein lysate on 4% polyacryl- 
amide gels. The 190-kD 13-galactosidase-octamer-binding fu- 
sion protein was visualized by briefly staining the gel with 
0.05% Coomassie Brilliant Blue R-250 in water and then des- 
taining with several changes of water. For the first injection of 
two New Zealand white rabbits, gel slices containing -50 ~g of 
fusion protein were macerated by passing through a syringe re- 
peatedly and emulsified in Freund's complete adjuvant (Harlow 
and Lane 1988). For subsequent injections, the fusion protein 
was recovered from the gel slice by electroelution i to 3 ml of 
0.2 M Tris-acetate (pH 7.4), 1% SDS, 100 rnM DTT, and precipi- 
tation with five volumes of acetone before resuspension i
water and emulsifying in Freund's incomplete adjuvant. Preim- 
mune serum was obtained before the first injection, and the 
rabbits were boosted every 2 weeks with 50 ~g of fusion protein 
after the first immunization. Five-milliliter test bleeds were 
obtained before each boosting to test for antibody production. 
One rabbit exhibited an immune response after the third injec- 
tion, as assayed by Western blotting of the fusion protein. This 
antiserum was subsequently used for the gel retardation assays. 
anti-Oct-1 antisera was added to the binding reaction, together 
with the cell extract in the 10-rain preincubation step in the 
absence of probe. 
Sequencing of oct-/ cDNAs 
Due to the presence of an internal EcoRI site, the cDNA insert 
of hC5 was excised as two EcoRI fragments and subcloned i to 
the EcoRI site of pUCll8. The nucleotide sequence of each 
fragment was determined by the shotgun method (Bankier and 
Barrell 1983). To prepare the random shotgun subclones, each 
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EcoRI insert was isolated preparatively on a polyacrylamide g l, 
self-ligated with T4 ligase, sonicated, end-repaired, and frag- 
ments size-selected {-400-1000 bpJ on a polyacrylamide g l. 
After elution, the fragments were blunt-end ligated into Sinai- 
digested and phosphatased M13mp8 phage vector. M13 single- 
stranded DNA templates were sequenced using the dideoxy 
method (Sanger et al. 1977}, and the data collected and com- 
piled in the Intelligenetics GENED program. Both fragments 
were sequenced in entirety on both strands. The junction be- 
tween the two EcoRI sites was ascertained by sequencing across 
the site in the pBSoct-1 + clone described below. 
To isolate additional oct-1 cDNAs, a hgtl0 library of cyto- 
plasmic polyadenylated RNA from NTera-2D1 human terato- 
carcinoma cells (Skowronski et al. 1988) was screened for oct-1 
eDNA clones by hybridization using standard methods (Man- 
iatis et al. 1982). Both of the 1.1- and 1.3-kb EcoRI fragments 
from KC5 were nick-translated and used as probe. After three 
rounds of plaque purification, DNA was prepared from each 
clone (Manfioletti and Schneider 1988), and the size of the 
cDNA inserts was determined by EcoRI digestion. This proce- 
dure resulted in the isolation of 16 new oct-1 cDNA clones. 
The longest clone obtained, hC7, was sequenced by the dideoxy 
method (Sanger et al. 1977), using forward and reverse hgtl0 
primers flanking the EcoRI cloning site according to the manu- 
facturer's specifications {New England Biolabs), and also with a 
21-nucleotide-long oligonucleotide corresponding to 2389- 
2409 of the oct-1 eDNA sequence shown in Figure 5 and di- 
rected toward the poly(A) sequence. 
In vitro transcription~translation of oct-/ cDNA 
To synthesize protein for the mapping of the Oct-1 DNA- 
binding domain, an AvaI-HpaII restriction fragment that spans 
the entire oct-l-coding sequence and includes 13 bp of down- 
stream hgtl 1 sequences from kC5 was cloned into the HincII 
site of pBSM13 + (Stratagene) by blunt-end ligation after end- 
filling of the 5' overhanging termini. The AvaI site was created 
by the ligation of the EcoRI linker to the 5' end of the oct-1 
sequences in KC5 (CC/CGAG) and in the pBS subclone lies 
adjacent to the pBS EcoRI site. This plasmid is called pBSoct- 
1 +. A BstXI-HinclI deletion, pBSoct-IABH, from this clone was 
made by digestion of plasmid DNA with these enzymes, blunt- 
ending of the 3' BstXI overhang with the large fragment of 
DNA polymerase I, and recircularization with DNA ligase. 
Generation of the correct junction sequence was ascertained by 
DNA sequencing. Plasmid DNA from these constructs was di- 
gested with restriction endonucleases and used as template for 
T7 RNA polymerase to transcribe uncapped RNA suitable for 
in vitro translation. The RNA templates (about 1 ~g) were used 
as mRNA in a rabbit reticulocyte lysate (Promega; 50 txl total 
volume) to translate [sSS]methionine-labeled protein, according 
to the manufacturer's specifications, and protein production 
confirmed by analysis of the reaction products on SDS-poly- 
acrylamide gels. Gel retardation analysis with a2p-radiolabeled 
DNA fragments was performed irectly using 1 txl of the trans- 
lation mix as described previously (Sturm et al. 1987) with the 
preincubation step described above. The gels were acid-fixed, 
dried, and exposed to two sheets of X-ray film to shield the top 
sheet from ass radiation but still allow the s2p-labeled DNA 
fragments to be detected. 
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